Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: ValuEngine, Inc.
Provider: ValuEngine, Inc.
Provider: Pechala's Reports

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Sorrento Therapeutics Inc Announces Full Exercise of Over-Allotment Option

Friday, 25 Oct 2013 04:10pm EDT 

Sorrento Therapeutics Inc announced the full exercise of the over-allotment option granted to the underwriters to purchase an additional 622,500 shares of common stock at a public offering price of $7.25 per share, bringing the expected total gross proceeds from the offering to approximately $34.6 million, before underwriting discounts and commissions and other offering expenses payable by Sorrento. Aegis Capital Corp. is acting as the sole book-running manager for this offering. 

Company Quote

26 Mar 2015